Recombinant SLC34A2 (Lifastuzumab Biosimilar) anticorps

N° du produit ABIN7597786

L’anticorps anti-SLC34A2 (Lifastuzumab Biosimilar) Chimeric produit chez le Humanized a été validé pour not_set. Il convient pour la détection de SLC34A2 (Lifastuzumab Biosimilar) dans des échantillons provenant de Humain. }

Aperçu rapide pour Recombinant SLC34A2 (Lifastuzumab Biosimilar) anticorps (ABIN7597786)

Antigène: SLC34A2 (Lifastuzumab Biosimilar)

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Humanized

Clonalité: Chimeric

Conjugué: Cet anticorp SLC34A2 (Lifastuzumab Biosimilar) est non-conjugé

Classe de qualité: Research Grade

Détail du produit anti-SLC34A2 (Lifastuzumab Biosimilar) anticorps

Expression System: Mammalian cells

Fonction: Research Grade Lifastuzumab Biosimilar Antibody

Specificité: Sodium/phosphate cotransporter 2B, Na(+)-dependent phosphate cotransporter 2B, Na(+)/Pi cotransporter 2B, Sodium-dependent phosphate transport protein 2B, NaPi3b, NaPi-2b, SLC34A2, Solute carrier family 34 member 2, Sodium-phosphate transport protein 2B

Purification: Protein A or G purified from cell culture supernatant.

Pureté: >95 % by SDS-PAGE.

Isotype: IgG1 kappa

Information d'application

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Stock: 4 °C,-20 °C,-80 °C

Stockage commentaire: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Date de péremption: 12 months

Détails sur SLC34A2 (Lifastuzumab Biosimilar)

Antigène: SLC34A2 (Lifastuzumab Biosimilar)

Autre désignation: Lifastuzumab Biosimilar

Classe de substances: Biosimilar

Sujet: Sodium/phosphate cotransporter 2B, Na(+)-dependent phosphate cotransporter 2B, Na(+)/Pi cotransporter 2B, Sodium-dependent phosphate transport protein 2B, NaPi3b, NaPi-2b, SLC34A2, Solute carrier family 34 member 2, Sodium-phosphate transport protein 2B

UniProt: O95436

Numéro CAS: 1615697-16-9